|
週次 |
日期 |
單元主題 |
|
第0週 |
09/16 |
週次 日 期 報告學生 授課教師
1 09.23 課程導論/林暄梅、曾宜萱 陳沛隆
2 09.30 王丹青、趙紹宇 陳佑宗
3 10.07 闕立芸、甘嘉敏 黃祥博
4 10.14 - -
5 10.21 陳品瑄、楊雅琇
潘思樺
6 10.28 郭力中、許慈恩 許書睿
7 11.04 碩甄、博甄招生口試 全體老師
8 11.11 洪楚嫣、馬一心 陳佑宗
9 11.18 謝奔浩 黃祥博
10 11.25 - -
11 12.02 博班修業進度報告、小蛋會
邱楚璿、劉昱希 主持人：陳姿宇
全體老師
12 12.09 博班修業進度報告、小蛋會
陳炫任、陳姿宇 主持人：邱楚璿
全體老師
13 12.16 洪崇凱、林暄梅、陳品瑄 許書睿、張以承
14 12.23 江鈺婷、曾宜萱、楊雅琇 黃祥博、潘思樺
15 12.30 趙紹宇、許慈恩、郭力中 張以承、陳沛隆
16 01.06 劉昱希、闕立芸、馬一心 陳佑宗、潘思樺
17 01.13 總檢討/王丹青、甘嘉敏
、洪楚嫣、謝奔浩 陳沛隆、許書睿
18 01.20 碩二修業進度報告、小蛋會 全體老師
|
|
第1週 |
9/23 |
曾宜萱/ 陳沛隆
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
林暄梅/ 陳沛隆
SCITO-seq single-cell combinatorial indexed cytometry sequencing. |
|
第2週 |
9/30 |
趙紹宇/陳佑宗
Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation.
王丹青/陳佑宗
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery. |
|
第3週 |
10/07 |
甘嘉敏/黃祥博
Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation.
闕立芸/黃祥博
Microvessels support engraftment and functionality of human islets and hESC-derived pancreatic progenitors in diabetes models. |
|
第5週 |
10/21 |
陳品瑄/潘思樺
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy.
楊雅琇/潘思樺
Cigarette smoke-induced LKB1AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC. |
|
第6週 |
10/28 |
許慈恩/許書睿
Membrane-bound Δ12 fatty acid desaturase (FAD12); From Brassica napus to E. coli expression system.
郭力中/許書睿
Tumor mutational burden assessment in non-small-cell lung cancer samples- results from the TMB2 harmonization project comparing three NGS panels.
|
|
第8週 |
11/11 |
洪楚嫣/陳佑宗
Chemical combinations potentiate human pluripotent stem cell-derived 3D pancreatic progenitor clusters toward functional β cells. |
|
第9週 |
11/18 |
謝奔浩/黃祥博
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy. |
|
第13週 |
12/16 |
洪崇凱,林暄梅,陳品瑄/許書睿、張以承
Exome sequencing and analysis of 454,787 UK Biobank participants. |
|
第14週 |
12/23 |
江鈺婷、曾宜萱、楊雅琇/黃祥博、潘思樺
Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells. |
|
第15週 |
12/30 |
趙紹宇、許慈恩、郭力中 / 張以承、陳沛隆 In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target.
|
|
第16週 |
1/06 |
劉昱希、闕立芸、馬一心/陳佑宗、潘思樺
主題:crispr therapy的應用
參考網址:
1. http://www.crisprtx.com
2. https://www.intelliatx.com
3. https://www.editasmedicine.com |
|
第17週 |
1/13 |
王丹青、甘嘉敏、洪楚嫣、謝奔浩/陳沛隆、許書睿
Control of the activity of CAR-T cells within tumours via focused ultrasound.
Nano-optogenetic engineering of CAR T cells for precision immunotherapy with enhanced safety. |